The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Seok-Hyun Kim
No relevant relationships to disclose
Gyeong-won Lee
No relevant relationships to disclose
Yi Yeong Jeong
No relevant relationships to disclose
Ho-Cheol Kim
No relevant relationships to disclose
Jong Deog Lee
No relevant relationships to disclose
Young Sil Hwang
No relevant relationships to disclose
In-Suk Kim
No relevant relationships to disclose
Suee Lee
No relevant relationships to disclose
Sung Yong Oh
No relevant relationships to disclose